Skip to main content
Free research Free research Free compound review with research home and workspace preview
Quick search ChEMBL 36
Compound Detail

CHEMBL4460351

Enter ChEMBL ID:
Free Research Context This compound will appear in recent viewed items on the research home for this browser.
Research home View demo workspace
Cc1cccc(NC(=O)c2nc(C)c([C@H](OC(C)(C)C)C(=O)O)c(-c3ccc(Cl)cc3)c2C)c1

Basic Information

ChEMBL ID CHEMBL4460351
Phase Preclinical
Structure Type MOL
InChI Key SCWYUUKBFWWSBE-DEOSSOPVSA-N
1
Targets
1
Activities
1
Assay Types
1
PK Parameters
2
Publications
0
Known Names

Molecular Properties

481.0
MW (Da)
6.52
ALogP
4
HBA
2
HBD
88.5
PSA (Ų)
0.42
QED
1
Ro5 Violations
6
Rot. Bonds

Drug Information

Molecule Type Unknown
Availability Unknown
Chirality Unknown

Flags

First in Class Prodrug

Extended Properties

Molecular Formula C27H29ClN2O4
MW 480.99
Aromatic Rings 3
Heavy Atoms 34
NP-Likeness -0.83

Activity Summary

EC50 1 meas. best 8.43

Target Activity Profile

Target Type Best pChEMBL Mean pChEMBL Best (nM) # Data
Unchecked
CHEMBL612545
EC50 8.43 8.43 3.7 1

Pharmacokinetic Data

Parameter Value Units Species
T1/2 5.0 hr Homo sapiens

Activity Data Samples

Top measurements by pChEMBL value

Target Type Rel. Value Units pChEMBL Assay PubMed
Unchecked EC50 = 3.7 nM 8.43 Inhibition of HIV NL4.3 integrase T124/T125 double mutant assessed as reduction ... 27563405

Literature References

PubMed DOI Target Context # Activities
27563405 10.1021/acsmedchemlett.6b00194 ADMET 1
27563405 10.1021/acsmedchemlett.6b00194 Unchecked 1

Data from ChEMBL 36 via Core Engine